Ibex Obtains CE-IVD Mark for AI-powered Cancer Detection

February 27, 2020

Ibex’s Galen™ Prostate solution demonstrates outstanding results in a blinded study and supports pathologists in providing accurate diagnosis, enhanced lab efficiency and quality control.

Read More

Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw

February 24, 2020

While the new money may have been raised under the looming threat of Covid 19, the company’s technology is already being used to test for infection-causing pathogens in immunocompromised pediatric patients, and for potential causes of complex pneumonia, fungal infections and endocarditis, according to a statement from the company.

Read More

Interview: Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

February 21, 2020

Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire.

Read More

Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company

December 24, 2019

Israel-based life sciences, healthcare, and technology venture capital firm aMoon, together with an unnamed private investor, invested $5 million in cancer drug startup NanoGhosts, aMoon told Calcalist. This is NanoGhosts’s first investment.

Read More

Seer Announces $55 Million in Series D Equity Financing Bringing in New Investors aMoon Fund and T. Rowe Price Funds

December 19, 2019

Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products

Read More

Newly Merged Voice Analysis Startups Healthymize and Beyond Verbal Raise $9 Million

December 10, 2019

The new entity, Vocalis Health, will develop technology for the voice-based analysis and detection of health issues such as heart and respiratory conditions and depression

Read More

Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch

October 29, 2019

The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.

Read More

aMoon invests in $80m Adicet Bio financing round

October 3, 2019

Based on technology developed by the Technion’s Prof. Yoram Reiter, Adicet Bio is developing allogeneic cell therapies for cancer using innovative gamma delta T cells.

Read More

MDClone, Developer of First Healthcare Synthetic Data Engine, Raises $26 Million

August 22, 2019

aMoon Leads New Investment Round with Participation from OrbiMed and Lightspeed Venture Partners.

Read More

Israel’s 10 ‘Hottest’ Startups In 2019, According to WIRED Magazine

August 21, 2019

Tel Aviv – has “the highest number of startups per capita in the world…with more than 6,000, of which 18 are unicorns…more than 100 venture capital funds, plus hundreds of accelerators and co-working places.”

Read More

Israel’s Zebra Medical gets FDA ok for AI chest X-ray product

May 13, 2019

Zebra Medical Vision said on Monday it received approval from the U.S. Food and Drug Administration for its artificial intelligence-based chest X-ray triage product.

Read More

Computational Pathology Pioneer Ibex Raises $11M

March 26, 2019

aMoon Fund leads round into developer of first ever clinically deployed AI Based Cancer Diagnosis system

Read More

Israeli migraine device co Theranica raises $35m

March 18, 2019

Nerivio Migra, the Netanya-based company’s novel remote neuromodulation device for acute treatment of migraine, is under review by the FDA.

Read More

Israeli health fund aMoon II raises $660 million

March 6, 2019

Israel-based healthcare fund aMoon II said on Wednesday it has received commitments of $660 million from investors. This is up from $600 million reported in January in an investor document obtained by Reuters.

Read More

A healthcare investment fund has become one of Israel’s largest with a $660 million close

March 6, 2019

One of Israel’s single largest venture capital funds is a new later stage vehicle focused on healthcare.

Read More

Ayala Pharmaceuticals to Present Preclinical Data at AACR for AL101, a Pan-Notch Inhibitor Being Evaluated for Adenoid Cystic Carcinoma

March 4, 2019

Results support the clinical development of AL101 as a targeted monotherapy for people with tumors bearing Notch activated mutations

Read More

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION

August 2, 2018

Advances Phase 2 Study in Alzheimer’s Disease in Canada, RPh201 development in US supported by Fast Track Designation by US Food and Drug Administration

Read More

Israeli firm creates particles to kill germs on contact, fight bacterial disease

August 2, 2018

With product initially aimed for dental industry, Petah-Tikva based Nobio raises $3.6 million from aMoon Fund and Dr. Ole Jensen, a US surgeon and dentist

Read More

Zebra Medical Vision gets $30M Series C to create AI-based tools for radiologists

June 7, 2018

Zebra Medical Vision, an Israeli medical imaging startup that uses machine and deep learning to build tools for radiologists, has raised a $30 million Series C led by health technology fund aMoon Ventures, with participation from Aurum, Johnson & Johnson Innovation—JJDC Inc.

Read More

Medial EarlySign’s clinical validation trial shows promise for detecting colorectal cancer

April 17, 2018

A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.

Read More